Pharmaceutical care and its relationship to prescribing behaviour of general practitioners
- 97 Downloads
To study the correlation between pharmaceutical care and prescribing routines of general practitioners (GPs).
Cross-sectional study; 201 pharmacies, 408 general practices, The Netherlands, 2000/2001. The variation in prescribing behaviour was characterised using 20 validated prescribing indicators based on general practice guidelines. The general construct ‘adherence to guidelines’ served as the dependent variable and was formed by summing the scores of the prescribing indicators. Four possible determinants of the variation were determined on the basis of survey questions: the construct ‘the pharmacist’s attitude towards pharmaceutical care’, and three partial constructs derived from the pharmacist’s care-providing function: the care for the individual patient, the cooperation with general practitioners and the registration of the care provided. A multiple linear regression analysis was then performed.
Main outcome measure
The weighted score for the prescribing indicators.
The weighted average score for the prescribing indicators was 65% (SD 3.7). The response rate to the survey was 71%. The pharmacist’s attitude to pharmaceutical care, as well as the degree to which the pharmacist provided care for the individual patient, the degree to which he cooperated with the general practitioner and the degree to which he registered the care provided were not correlated with the ‘adherence to guidelines’ by the general practitioner with whom the pharmacist frequently cooperated.
Variations between general practitioners in the quality of prescribing, as measured by their adherence to guidelines, were not correlated with pharmaceutical care by the pharmacist with whom they cooperated on a day-to-day basis.
KeywordsCooperation General practitioner Indicators Pharmacist Pharmaceutical care Pharmacotherapy Prescribing indicators Prescribing quality The Netherlands
We thank the community pharmacists who participated in this study.
Funding: Royal Dutch Association for the Advancement of Pharmacy (KNMP) and CZ health insurance company.
- 8.Muijrers PEM, Janknegt R, Sijbrandij J, Grol RP, Knottnerus JA Prescribing indicators. Development and validation of guideline-based prescribing indicators as an instrument to measure the variation in the prescribing behaviour of general practitioners. Eur J Clin Pharmacol 2004;60(10):739–46.PubMedCrossRefGoogle Scholar
- 10.Van Mil JWF. Pharmaceutical care, the future of pharmacy. Theory, research and practice. (Dissertation). University of Groningen. The Netherlands; ISBN: 90-9013367-4, 1997.Google Scholar
- 11.Van der Heide H, Tinke JL. Facts and figures, cost development of pharmaceutical aid. The Hague, The Netherlands: Foundation for Pharmaceutical Statistics; 1999.Google Scholar
- 17.Kocken GA. Medication discussion groups in the Netherlands: five years of experience. Med Educ 1999;33(5):390–3.Google Scholar
- 22.Carroll NV. Do community pharmacists influence prescribing? J Am Pharm Assoc (Wash DC) 2003;43(5):612–21.Google Scholar
- 23.Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes (Cochrane Review). In: The Cochrane Library, vol. 4. Oxford; 2001.Google Scholar
- 24.Guidelines for ATC classification and DDD assignment. Oslo: World Health Organization Collaborating Centre for Drug Statistics Methodology. 2004. Available at: http://www.whocc.no/atcddd/indexdatabase/index.php. Accessed 1 february 2005.
- 25.Vektis BV. Externe integratie declaratie farmaceutische hulp. 1995 [External integration of declarations for pharmaceutical help]; available at http://www.vektis.nl/index.php. Accessed 1 February 2005.
- 26.Koninklijke Nederlandsche Maatschappij tot bevordering der Geneeskunst: Eisen en voorwaarden herregistratie huisartsen. [The Royal Dutch Medical Association: requirements and conditions for reregistration of general practitioners]. Staatscourant 2003;47:18.Google Scholar
- 30.Sellors J, Kaczorowski J, Sellors C, Dolovich L, Woodward C, Willan A et al. A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. Can Med Assoc J 2003;169(1):17–22.Google Scholar
- 33.De Vries CS. Collaboration in healthcare. The tango to drug safety. Dissertation. University of Groningen. The Netherlands;1998Google Scholar
- 35.Muijrers PEM, Knottnerus JA, Sijbrandij J, Janknegt R, Grol RPTM. Differences in prescribing between general practitioners. Impact of the cooperation with pharmacists and impact of visits from pharmaceutical industry representatives. Fam Pract (In press, accepted for publication June 29th 2005).Google Scholar
- 36.Van Dijk L, Barnhoorn H, De Bakker D. Het Farmacotherapie Overleg in 1999, stand van zaken en effecten op voorschrijven [The Pharmacotherapeutic audit meeting in 1999, current state of affairs and effects on prescribing]. Nivel, Utrecht, The Netherlands; 2001.Google Scholar